Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

FJ Neumann, A Kastrati, T Miethke, G Pogatsa-Murray… - The Lancet, 2001 - thelancet.com
Summary Background Vascular infection with Chlamydia pneumoniae might boost
inflammatory responses that play a pivotal part in neointima formation, which is the main …
被引用次数：168 相关文章

[引用][C] Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised …

FJ NEUMANN, A KASTRATI, T MIETHKE… - Lancet (British …, 2001 - pascal-francis.inist.fr
Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima
proliferation after coronary stent placement (ISAR-3) : a randomised, double-blind, placebo-controlled …

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

FJ Neumann, A Kastrati, T Miethke… - THE LANCET, 2001 - thelancet.com
Summary Background Vascular infection with Chlamydia pneumoniae might boost
inflammatory responses that play a pivotal part in neointima formation, which is the main …

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

FJ Neumann, A Kastrati, T Miethke, G Pogatsa-Murray… - 2001 - cabidigitallibrary.org
Vascular infection with C. pneumoniae might boost inflammatory responses that play a
pivotal part in neointima formation, which is the main cause of restenosis after stenting. To …

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

F Neumann, A Kastrati, T Miethke… - Lancet (London …, 2001 - pubmed.ncbi.nlm.nih.gov
Background Vascular infection with Chlamydia pneumoniae might boost inflammatory
responses that play a pivotal part in neointima formation, which is the main cause of …

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

FJ Neumann, A Kastrati, T Miethke, G Pogatsa-Murray… - The Lancet, 2001 - Elsevier
BACKGROUND: Vascular infection with Chlamydia pneumoniae might boost inflammatory
responses that play a pivotal part in neointima formation, which is the main cause of …

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

FJ Neumann, A Kastrati, T Miethke, G Pogatsa-Murray… - The Lancet, 2001 - infona.pl
Vascular infection with Chlamydia pneumoniae might boost inflammatory responses that
play a pivotal part in neointima formation, which is the main cause of restenosis after …

[引用][C] Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised …

FJ Neumann, A Kastrati, T Miethke - The Lancet, 2001 - elibrary.ru
Presents a study which investigated whether or not treatment of Chlamydia pneumoniae
infection with antibiotics prevents restenosis after coronary stent placement. Background; …

Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double …

F Neumann, A Kastrati, T Miethke… - Lancet (London …, 2001 - europepmc.org
Background Vascular infection with Chlamydia pneumoniae might boost inflammatory
responses that play a pivotal part in neointima formation, which is the main cause of …

[引用][C] Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised …

FJ NEUMANN, A KASTRATI, T MIETHKE… - Lancet, 2001 - Elsevier